Forward Therapeutics, Inc.

Forward Therapeutics is a biopharmaceutical company focused on developing novel, next-generation small molecule immune therapies to transform the treatment of chronic inflammatory disorders. The company boasts a team of leading scientific experts with a proven track record in drug discovery and development. Forward Therapeutics leverages cutting-edge capabilities and an integrated discovery and development model to advance its pipeline of promising therapies. Their approach targets validated immunology targets with the potential to significantly improve patient care and deliver blockbuster impacts.

Forward Therapeutics has secured $50 million in Series A financing, led by BVF Partners LP with participation from other prominent life sciences investors like RA Capital Management and OrbiMed. This funding will support the advancement of their portfolio of novel, small molecule immunology medicines towards clinical development. The company is committed to achieving its business objectives in compliance with all federal, state, and local laws, and is dedicated to building a diverse and inclusive organization.

Forward Therapeutics is a biopharmaceutical company committed to transforming the treatment of chronic inflammatory disorders. They strive to develop novel, next-generation small molecule immune therapies to improve the lives of millions affected by these conditions.

Forward Therapeutics fosters a culture of innovation, collaboration, and a commitment to addressing chronic inflammatory diseases. The company emphasizes a dynamic environment where employees are empowered to make a meaningful impact, working alongside top-tier scientific minds. This shared passion for advancing science translates to a driven and dedicated team striving to create a healthier future.

Forward Therapeutics is committed to building a diverse and inclusive organization. They believe in measuring each applicant, candidate, and employee based on their qualifications for the role, regardless of age, sex, religion, sexual orientation, gender identity, national origin, Veteran status, disability, and/or any other protected class characteristics. Forward Therapeutics is dedicated to achieving all business objectives in compliance with all federal, state, and local laws.